Corticosteroids for Duchenne Muscular Dystrophy: Translating Evidence into Practice

Duchenne muscular dystrophy (DMD) is the most common childhood muscular dystrophy (annual incidence, about 1 in 5000 male live births). In the disorder's devastating natural history, boys lose the ability to ambulate at a mean age of 9 years and die at a mean age of 19 years. Although DMD patients have long been known to benefit from corticosteroids, widespread varriation in practice …